Skip to main content
logo
IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
3.080
0.00 (0.00%)
At close: Aug 7, 2026, 4:00 PM EDT
3.120
+0.040 (1.30%)
After-hours: Aug 7, 2026, 7:50 PM EDT

IceCure Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.573.383.293.233.094.14
Revenue Growth
8.92%2.67%1.92%4.67%-25.45%6.98%
Cost of Revenue
2.262.151.841.931.641.94
Gross Profit
1.31.231.451.31.452.2
Selling, General & Admin
9.018.8910.058.69.066.04
Research & Development
7.987.437.18.279.125.88
Total Operating Expenses
16.9916.3217.1516.8818.1811.92
Operating Income
-15.68-15.09-15.7-15.58-16.74-9.72
Total Non-Operating Income (Expense)
-0.030.040.380.92-0.24-0.17
Pretax Income
-15.71-15.06-15.32-14.65-16.98-9.9
Net Income
-15.71-15.06-15.32-14.65-16.98-9.9
Net Income to Common
15.7415.0615.3214.6516.989.9
Net Income Growth
2.92%-1.70%4.54%-13.70%71.58%165.28%
Shares Outstanding (Basic)
322211
Shares Outstanding (Diluted)
322211
Shares Change
51.45%43.72%11.48%23.29%29.66%66.67%
EPS (Basic)
5.826.18-9.00-9.60-13.80-10.50
EPS (Diluted)
5.826.18-9.00-9.60-13.80-10.50
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-14.89-14.61-12.63-13.03-15.18-13.14
Free Cash Flow Growth
------
Free Cash Flow Per Share
-5.50-5.99-7.45-8.57-12.31-13.81
Gross Margin
36.55%36.28%44.09%40.26%46.84%53.04%
Operating Margin
-439.94%-446.70%-476.94%-482.38%-542.59%-234.99%
Profit Margin
-440.76%-445.61%-465.45%-453.76%-550.34%-239.13%
FCF Margin
-417.62%-432.38%-383.89%-403.53%-492.16%-317.50%
EBITDA
-15.41-14.8-15.36-15.25-16.49-9.6
EBITDA Margin
-432.23%-437.97%-466.85%-472.38%-534.55%-231.92%
EBIT
-15.68-15.09-15.7-15.58-16.74-9.72
EBIT Margin
-439.94%-446.70%-476.94%-482.38%-542.59%-234.99%
SEC Filings: 10-K · 10-Q